drugset / Trial / NCT00417950

Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes

NCT00417950

RandomizedSingle-groupOpen-labelTreatment

Summary

To understand if acarbose, an alpha-glucosidase inhibitor usually for treating diabetes, will further lower post meal glucose and inflammatory state when taking together with moderate amount of alcohol during meal tolerance test in subjects with impaired glucose tolerance or mild diabetes.

Timeline

Start
2007-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Acarbose Unknown